ibuprofen, (r)-isomer has been researched along with naloxone in 3 studies
Studies (ibuprofen, (r)-isomer) | Trials (ibuprofen, (r)-isomer) | Recent Studies (post-2010) (ibuprofen, (r)-isomer) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
---|---|---|---|---|---|
10 | 0 | 4 | 20,134 | 1,257 | 3,321 |
Protein | Taxonomy | ibuprofen, (r)-isomer (IC50) | naloxone (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
1 review(s) available for ibuprofen, (r)-isomer and naloxone
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for ibuprofen, (r)-isomer and naloxone
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |